NFKB1 and Miyoshi myopathy: Because a key pathogenetic activity of NF-κB in MM is to block apoptosis through the induction of target genes, an attractive alternative to globally targeting NF-κB would be to block the nonredundant, cancer-specific downstream effectors of the NF-κB survival function; these effectors, however, are not known.